Mauricio Vladim...'s profileMauricio VladimirPhotosBlogListsMore  |  Tools Help |
Mauricio VladimirWelcome to the Jungle!
|
March 14 Panales de Abejas ComputadorasLa idea de una computadora creadora de realidad puede empezar con esta formula:
REALIDAD = ENERGIA.TIEMPO.LUZ; extiende OBJETOS COMPLEJOS
REALLITY = ENERGY.TIME.LIGHT; extends COMPLEX OBJECTS
en la creacion seria una pila de cesio, una matriz de datos complejo dimensional y un proyector holografico.
la forma seria como la de panal de abeja para conectarlas en el suelo una a la par de la otra.
Soy Ingeniero que uso PCs con Windows y Linux
Me gusta ser como Steve Jobs aunque no lo conozco mucho.
Atte.
Mauricio Fuentes. June 14 BuscaniguasAqui esta el screenshot del Buscaniguas Original... Este comenzo con una indexacion que hice del dominio SV en 1998 usando el motor de Lycos, yo ya tenia unos 5 años programando y manteniendo Paginas Web, luego Lycos nos prohibio el uso debido a que la licencia no permitia indexar todo un supradominio el dominio .sv, Don Fernando Lara dueño de Enlinea se molesto porque Lycos se dio cuenta que usabamos su motor, pero yo lo notifique por ser cuestiones de regla, ya que no podiamos tener un producto completo si no cumplia las licencias. Luego una carrera loca nos llevo a buscar alternativas como el motor de Altavista, ya que para esa epoca Google no existia, y ademas aunque existiera para la solucion que necesitabamos, habia que invertir... El motor de Altavista cobraba 10,000 dolares por 1,000 paginas indexadas si mal no recuerdo... El registro original de Buscaniguas tenia alrededor de 30,000 paginas... Probamos un motor que se llamaba Phantom, pero era comprado, costaba como 440 dolares y esa fue la palabra clave, "comprado"... yo y el diseñador hicimos un trabajo que luego fue vendido en una onerosa cantidad a GPremper, aunque al inicio el Sr. Richter no lo queria vender ya que le daba algo de orgullo para el y su Cybercafe, un gringo loco puso dinero sobre la mesa pero no hubo respuesta, ademas ese trabajo lo hicimos de buena fe, entre dos personas, yo no pensaba en ganar pensaba solo en probar nuevas formas y tecnologias de desarrollo, en ese sentido habia una discordancia entre lo que se hacia y lo que se esperaba, claro Phantom era comprado y claro no lo compraron; esto fue en la empresa Enlinea, empresa que por cierto quebro como el fin de muchas empresas de vision cortoplacista... Phantom termino instalado en otra Empresa que se llama CyTec, pero Cytec por alguna razon ya no le dio seguimiento... Entonces el Sr. Richter Q.E.P.D. sugiro usar tecnologia Linux que aseguró que ahi podiamos encontrar algo y claro encontramos a HTDIG, un motor que se adapto perfectamente a la necesidad del buscador... Como les dije, Buscaniguas fue vendido, a mi ni me avisaron, menos me dijeron, ma aqui hay dinero para tus gastos, pero bueno esa es otra historia... Ahora el Sr. Premper convirtio el Buscaniguas en un Directorio, quitandole lo que le habia dado nacimiento... El Indexador y el Motor de Busqueda aunque ha invertido quiza en un par de rediseños... Habria que ver cuantas generaciones mas dura Buscaniguas, que sigue teniendo muchas visitas. El original era sencillo, pero tenia el poder de un motor de busqueda y los inicios de algunas secciones interesantes como La Pared de Grafiti, Que ondas El Finde, Sitios Recomendados, lo Nuevo y la Guaza que era un disparador de sitios al azar, El Buscaniguas no fue el primer motor de busqueda, ya existia Mirador, pero si a mi juicio dio el sentimiento que en el pais se pueden trabajar cosas buenas. Yo en lo personal he andado en varias empresas ya, buscando el equilibrio entre lo que es el desarrollo y las necesidades economicas de los patronos algo que siento que es muy pero muy dificil... January 05 Un vistaso a lo existente en hologramaslaser, luz, laser, luz...
habria que ver quien juega con la temperatura y las nano dimensiones... December 03 La realidad impone su leySin palabras - La realidad impone su ley...
November 11 Los geeks hemos tomado nuestro valorTodos los anuncios que desprestigian a los NERDS deberian de ser mas creativos, ya que los geeks aparte de ser el motor de la sociedad moderna hemos tomado nuestro valor, sino lean la cancion del software libre ( http://www.gnu.org/music/free-software-song.html ) Join us now and share the software; You'll be free, hackers, you'll be free. x2 Hoarders may get piles of money, That is true, hackers, that is true. But they cannot help their neighbors; That's not good, hackers, that's not good. When we have enough free software At our call, hackers, at our call, We'll throw out those dirty licenses Ever more, hackers, ever more. Join us now and share the software; You'll be free, hackers, you'll be free. x2 October 28 Mi planta favorita "el Barrigon"Bueno a pesar de no tener animal favorito, si tengo una planta favorita, es la mas resistente y adaptable a las condiciones extremas, ninguna animal se atreve a comersela por su fuerte veneno y puede incluso servir para hacer biodiesel
mas detalles tomados de:
- Nombre científico o latino: Jatropha podagrica - Nombre común o vulgar: Jatrofa, Tártago - Familia: Euphorbiaceae (Euforbiáceas). - Origen: América Central. - Planta curiosa, en el límite de las plantas crasas, pero frecuentemente tratada como tal. - Fácilmente reconocible por su tronco abultado por lo base. - Altura de 30 cm a 1 m, en casa. - Hojas caducas. - Flores agrupadas en tres, aparecen en el ápice de un tallo deshojado, rojo coral o anaranjado, durante todo el verano. - Se encuentra con facilidad en las floristerías debido a su floración de color coral y su gracioso follaje ligeramente glauco. - Vive más de 15 años. - El pie abultado se hace cada vez más espectacular con la edad. - Precaución: el látex blanco que fluye de los heridas, causados por un golpe o simplemente por la caída de una hoja, es muy tóxico. Evite cualquier contacto con los ojos y los mucosas. - CULTIVO - Jatropha es una especie de los bosques y requiere una tierra humífera y riegos regulares. - Luz: gusta de un sitio con mucha luz, preferiblemente soleado. - Temperaturas: en una habitación cálida. - Humedad ambiental: ambiente más seco en invierno que en verano. Tolera bien el ambiente seco. - Substrato: arena de río, turba rubia y mantillo de hojas, con un 25% de grava fina. - Riego: proporciónale un riego medio cuando tenga hojas. - Regar cada 7 ó 10 días en primavera y en verano, 1 vez al mes en otoño e interrumpir en invierno. - Al final de la temporada las hojas amarillean y caen, y ya no hay que regar. - La Jatropha necesita una parada vegetativa bien marcada en invierno. - Abono: en primavera y verano (Hemisferio Norte, desde abril hasta septiembre), añadir una vez al mes un abono líquido paro cactáceas. - Plagas: cochinillas. - Trasplante: cambio de maceta en primavera, cada 2 años. - Elija para los trasplantes una maceta bastante honda, de manera que quepan sin problemas las gruesas raíces carnosas. - Multiplicación: en semillero, a 24ºC, en primavera. October 27 El reencuentro de Maradona y ‘Mágico’ GonzálezEl reencuentro de Maradona y ‘Mágico’ González
Fuente: http://www.elpais.es/articulo/deportes/elppordep/20061027elpepudep_1/Tes/ El futbolista argentino viaja al Salvador
EP/ AP - San Salvador ELPAIS.es - Deportes - 27-10-2006 - 11:07 Maradona llega al aeropuerto de San Salvador (EP)
ampliar MARADONA Nacimiento: 30-10-1960 (Villa Florito) Coincidieron en la Liga española y ahora se enfrentarán en en un partido de showbol , una modalidad parecida al fútbol sala. Diego Armando Maradona viajó ayer al Salvador dónde le esperaba , el ex jugador del Cádiz, Jorge 'Mágico' González. El jugador argentino fue recibido en el aeropuerto de la capital de Salvador por 'Mágico' González contra el que Maradona se enfrentó cuando militó en el Barcelona a principios de la década de 1980 cuando el salvadoreño jugaba en el Cádiz.
Hoy el argentino dará una conferencia de prensa y tiene planeado visitar un hospital de niños de la capital, informaron los organizadores.
El sábado los jugadores se enfrentarán en el estadio Cuscatlán, con capacidad para más de 25.000 aficionados, y en el que Maradona jugará contra ex internacionales de El Salvador que se clasificaron para el Mundial de 1982 de España y que estarán encabezados por 'Mágico' González.
Acercandose a la Idea del HologramaTech Pioneers
Bueno, quien diria que la idea del holograma esta lejos, ya esta en fase experimental el hecho de separar las propiedades de la materia y para obtener propiedades diferentes para manipularlas, como lo hacen, lean este articulo:
Sometimes you have to quit what you're doing to pursue your ideas. These scientists took the risk--and it paid off
Who says there's no such thing as a eureka moment? Physicist David Grier sure had one. Grier and graduate student Eric Dufresne were trying to build a new kind of "optical trap"—a device that splits a laser beam and uses it to capture particles of a single substance. They knew that multiple traps, used in tandem, could let scientists play traffic cops on a molecular level, separating a substance into component parts—removing bacteria from blood, for example. For a year, Grier and Dufresne had been trying out fancy glass splitters, but nothing had done the trick. As a joke, Grier tried a $5 piece of plastic. "It should not have worked," he says. But it did: the "cheesy piece of plastic" split the laser beam into 16 parts, which gave the two scientists the potential to capture 16 separate substances. It was the breakthrough they had long been after. "We were stunned," Grier recalls.
That aha! has paid off. Soon afterward, in 2000, Grier co-founded Arryx, an optical-equipment company whose laser gear can grab, trap and move minute particles of just about anything. The firm expects to make a profit this year—impressive progress for a biotech start-up. Arryx is one of 29 "Technology Pioneers" chosen by the World Economic Forum, the Geneva-based nonprofit organization best known for its annual meeting in Davos, Switzerland, which opens this year on Jan. 26. Others on the pioneers list—including technologists in the fields of energy, biotech and information—have become entrepreneurs too. The biotech scientists have achieved some extraordinary breakthroughs, but to do that, many had to leave comfortable corporate or academic jobs in which they were confined by institutional thinking.
At the California Institute of Technology, for example, Bassil Dahiyat and his professor Stephen Mayo ran into resistance when they proposed a new approach to fighting disease. They argued that because protein shapes vary according to their functions, it should be possible to create new disease-fighting proteins by first imagining their shape. "You could hear the people at Caltech snicker," says Dahiyat.
Determined to prove the naysayers wrong, Dahiyat went to the supercomputer at Caltech's famed Jet Propulsion Laboratory. "I said, 'Here's the shape I want to make. Tell us the sequence,'" he recalls. By the end of the day, the computer gave him billions of possible amino-acid combinations and recommended the best one. Dahiyat threw that sequence into a small, tunnel-like device. About a minute later, he noticed that the protein was taking form. "I could see it wasn't spaghetti," he says. "I said, 'Oh, my God, we've got structure!'"
Dahiyat and his professor may have the last laugh. In 1997 they founded Xencor, with Dahiyat in charge, based on the protein-creation process called Protein Design Automation (PDA) that they had refined on the supercomputer. If all goes as planned, in about a year Xencor will start human trials of a protein that combats multiple sclerosis, rheumatoid arthritis and other diseases. Xencor has signed contracts with Genentech, Eli Lilly and other companies to develop additional drugs.
Jennie Mather left biotech company Genentech also out of frustration when, she says, her bosses wouldn't accept her approach to fighting cancer. She argued that what really counts in a target protein—that is, a protein that causes a disease and that a drug would aim to disable—is the protein's surface. Because a body's natural antibodies do their work entirely on the cell's exterior, she reasoned, drugs should work the same way. Such thinking was heresy to Genentech, whose scientists, she says, generally analyze a target's entire genetic structure. "They were just interested in genomics," she says. "There are 500 to 1,000 genes in a disease—the problem is, it takes a long time to understand what 1,000 genes do." Genentech says it pioneered the use of antibodies that target the surface protein of cancer, and its popular drugs work on that principle. Nevertheless, Mather saw a way to carve several years out of drug development and left to found Raven Biotechnologies, a drug-discovery company based in South San Francisco. She created a process to keep cells alive outside the body, so she could test her theory in the lab. Her efforts paid off. In December the U.S. Food and Drug Administration approved one of her drugs for human testing. The drug, called RAV 12, is a protein that in the dish destroys another protein found in 90% of all gastrointestinal cancers and in 50% of all breast, lung and prostate cancers.
Similarly, Harren Jhoti left pharmaceutical giant Glaxo Wellcome (now GSK) in 1999 when he realized that his unconventional idea of how to find new drugs to attack disease-causing proteins might never be realized unless he pursued it himself. He founded Astex, based in Cambridge, England, so he could develop his own flexible approach to molecular research. He calls it "fragment based," because rather than throwing an entire proposed drug molecule at the target protein, he throws just pieces at a time.
Jhoti and four of his scientists hit the pub when they had their eureka moment. In October 2002 their advanced X-ray and crystal technique revealed that a chemical was binding to a protein that is a possible cause of Alzheimer's disease. The chemical was a fragment of what could eventually become an Alzheimer's-conquering drug. "I first thought the team had played a trick on me," says Jhoti. Drug giant AstraZeneca, which had been searching for such a chemical for years, enlisted Astex's help. In 2003 the company signed a contract to pay Astex $40 million if Astex hits milestone breakthroughs and to make royalty payments once AstraZeneca sells drugs based on Astex's technology. "AstraZeneca worked on it for four years. We delivered an early candidate within a year of signing with them," says Jhoti. He also hopes to win regulatory approval to begin testing a general anticancer drug in the first half of 2005.
At Arryx, Grier and Dufresne's 16-trap breakthrough was so exciting that the University of Chicago, where they were based, showcased their work to Lewis Gruber, a biotech entrepreneur and patent lawyer. Within months, he had invested in the technology, and Arryx was born, with Gruber as chief executive. Grier, who is now a professor at New York University, is the company's chief scientific adviser. Grier and company have long since replaced the plastic with a liquid-crystal device, which they build into a small, box-shaped machine that you could call a cell catcher. The technology is used today for tasks that include analyzing blood and separating sperm cells in bull semen that produce bulls from those that make cows (which might not seem important unless you're a dairy farmer who needs a supply of milk-producing females). In late October, blood-equipment maker Haemonetics Corp., of Braintree, Mass., invested $5 million in Arryx to help develop a machine that would remove a blood donor's platelets, used for clotting. Under the deal, Haemonetics has agreed to make payments of $7.3 million and $5 million when Arryx hits predetermined development breakthroughs.
As entrepreneurial as some of these tech pioneers are, and as brilliant as their breakthroughs are, the R.-and-D.-reliant business of biotech is still very difficult. While the companies are developing processes and drugs, they survive on venture financing and funding from larger partners, often provided when they hit milestones. Payments from AstraZeneca and other partners have boosted Astex's revenues 170% annually since 2000, and Astex has raised $100 million in venture financing. Raven has raised $66 million and hopes to land another $35 million soon. It also receives milestone payments from Abbott Laboratories and others.
The big payout doesn't kick in until regulators approve the drugs for commercial use and the developers start receiving royalties, which can take years. "There are a lot easier ways to [make money] than to put your life into a high-risk adventure," says Dahiyat. Fortunately, the occasional chance to shout "Eureka!"—or at least, "We've got structure!"—also keeps their innovators going. October 24 Arroba de Oro 2006Felicidades a mis compañeros, por los logros que seguimos obteniendo a nivel de empresa en la Arroba de Oro
Aqui los semifinalistas de nuestra empresa...
Aplicaciones y Servicios en Internet
Arte
Asociaciones
Banca y Finanzas
E-commerce
Gobierno
Institucional
MIPYME Artesania
MIPYME Manufactura MIPYME Servicios
MIPYME Servicios
Rayo en PalmeraQuien diria, que los rayos no caen cerca... Este cayo justo detras de la oficina, donde un vecino... October 23 Poesia personal en InglesCries
In the beginning, was the spirit
then the spirit feels alone and begins to cry... Its cries creates the world...
Then the world continues crying
crying and crying... At last everything falls into the black hole
the spirit frees and continue crying, crying and dying.... The tunnel Dog are you dead?
Dog are you dead? Perpetual silence... Dog are you dead?
Dog are you dead? Perpetual silence... Dog, by now I'm dreaming with you...
you was my best friend... hello dog, come with me come in, come in.. Dog are you dead?
Don't be afraid just go for the tunnel kerberos is sleeping now Dog are you dead?
Perpetual silence... Anger
Anger who possess my body
anger who make me hates my boss after I type a wrong song anger of a loser anger of a wanker anger of a wrong programmer what the hell is the programer
without those impertinent mannagers who lives without themselves what the hell do you are? sorry if my typing makes noise in your hear
sorry if my verses cause another wrong code sorry if you lost a penni for my endless time sorry boss sorry for my anger... The leaves of a tree
I see you... can you see me? I feel you even you can't I hate you Even you loves me... Touch me, touch me holographic tree OrianitaLas venezolanas son lindas desde pequeñas, logico no... esto es una prueba ello... Orianita es una linda amiga de venezuela que conoci una vez en Internet En mi trabajoMi trabajo es una de las cosas que mas me gustan, ahi hay todo tipo de personal creativo y de programacion, Rodrigo mi amigo me tomo una foto sentado, espero les guste sobre todo porque me encuentro alegre... October 22 Libro de el Universo HolograficoGracias Kurt de Colorado Usa, por regalarme el libro de el Universo Holografico, me parece que los materiales seran manipulados de forma intagible en un futuro no muy lejano, sera como tener software palpable, con costos mas en la parte logica que en la parte fisica, sera un boom, sera como cocinar verdura holografica, sera el despertar de la matrix...
|
||||||||||||||||||||||||||||||||||||||||||||||||
Send a private message
Subscribe to RSS feed
Tell a friend
Add to My MSN
Add to your network
Sign up for alerts
|
|
